These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24121625)

  • 1. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells.
    Oram RA; Jones AG; Besser RE; Knight BA; Shields BM; Brown RJ; Hattersley AT; McDonald TJ
    Diabetologia; 2014 Jan; 57(1):187-91. PubMed ID: 24121625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.
    Oram RA; McDonald TJ; Shields BM; Hudson MM; Shepherd MH; Hammersley S; Pearson ER; Hattersley AT;
    Diabetes Care; 2015 Feb; 38(2):323-8. PubMed ID: 25519449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.
    Williams GM; Long AE; Wilson IV; Aitken RJ; Wyatt RC; McDonald TJ; Wong FS; Hattersley AT; Williams AJ; Bingley PJ; Gillespie KM
    Diabetologia; 2016 Dec; 59(12):2722-2726. PubMed ID: 27591853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.
    Hope SV; Knight BA; Shields BM; Hattersley AT; McDonald TJ; Jones AG
    Diabet Med; 2016 Nov; 33(11):1554-1558. PubMed ID: 27100275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting and meal-stimulated serum C-peptide in long-standing type 1 diabetes mellitus.
    Vollenbrock CE; Mul D; Dekker P; Birnie E; de Vries-Velraeds MMC; Boesten L; Groen J; Geelhoed-Duijvestijn PHLM; Aanstoot HJ; Wolffenbuttel BHR
    Diabet Med; 2023 Feb; 40(2):e15012. PubMed ID: 36398450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
    Thivolet C; Marchand L; Chikh K
    Diabetologia; 2019 Apr; 62(4):593-597. PubMed ID: 30612138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES.
    Steenkamp DW; Cacicedo JM; Sahin-Efe A; Sullivan C; Sternthal E
    Endocr Pract; 2017 Dec; 23(12):1387-1393. PubMed ID: 29144809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of residual β cell function in long-standing type 1 diabetes.
    Sherr JL; Ghazi T; Wurtz A; Rink L; Herold KC
    Diabetes Metab Res Rev; 2014 Feb; 30(2):154-62. PubMed ID: 24115337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
    McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
    Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes.
    Davis AK; DuBose SN; Haller MJ; Miller KM; DiMeglio LA; Bethin KE; Goland RS; Greenberg EM; Liljenquist DR; Ahmann AJ; Marcovina SM; Peters AL; Beck RW; Greenbaum CJ;
    Diabetes Care; 2015 Mar; 38(3):476-81. PubMed ID: 25519448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9.
    Hernandez M; Mollo A; Marsal JR; Esquerda A; Capel I; Puig-Domingo M; Pozzilli P; de Leiva A; Mauricio D;
    BMC Endocr Disord; 2015 Jan; 15():1. PubMed ID: 25572256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin micro-secretion in Type 1 diabetes and related microRNA profiles.
    Januszewski AS; Cho YH; Joglekar MV; Farr RJ; Scott ES; Wong WKM; Carroll LM; Loh YW; Benitez-Aguirre PZ; Keech AC; O'Neal DN; Craig ME; Hardikar AA; Donaghue KC; Jenkins AJ
    Sci Rep; 2021 Jun; 11(1):11727. PubMed ID: 34083567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes.
    Hope SV; Jones AG; Goodchild E; Shepherd M; Besser RE; Shields B; McDonald T; Knight BA; Hattersley A
    Diabet Med; 2013 Nov; 30(11):1342-8. PubMed ID: 23659458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.
    Liu EH; Digon BJ; Hirshberg B; Chang R; Wood BJ; Neeman Z; Kam A; Wesley RA; Polly SM; Hofmann RM; Rother KI; Harlan DM
    Diabetologia; 2009 Jul; 52(7):1369-80. PubMed ID: 19418039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes.
    Sims EK; Bahnson HT; Nyalwidhe J; Haataja L; Davis AK; Speake C; DiMeglio LA; Blum J; Morris MA; Mirmira RG; Nadler J; Mastracci TL; Marcovina S; Qian WJ; Yi L; Swensen AC; Yip-Schneider M; Schmidt CM; Considine RV; Arvan P; Greenbaum CJ; Evans-Molina C;
    Diabetes Care; 2019 Feb; 42(2):258-264. PubMed ID: 30530850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal.
    Pozzilli P; Raz I; Peled D; Elias D; Avron A; Tamir M; Eren R; Dagan S; Cohen IR
    Diabetes Care; 2014; 37(5):1384-91. PubMed ID: 24408401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of insulin administration during the mixed meal tolerance test.
    Besser RE; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
    Diabet Med; 2012 Oct; 29(10):1279-84. PubMed ID: 22435709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
    Jones AG; Besser RE; McDonald TJ; Shields BM; Hope SV; Bowman P; Oram RA; Knight BA; Hattersley AT
    Diabet Med; 2011 Sep; 28(9):1034-8. PubMed ID: 21843301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating adiponectin concentration is inversely associated with glucose tolerance and insulin secretion in people with newly diagnosed diabetes.
    Weber KS; Strassburger K; Pacini G; Nowotny B; Müssig K; Szendroedi J; Herder C; Roden M;
    Diabet Med; 2017 Feb; 34(2):239-244. PubMed ID: 27770592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.